Skip Content
You are currently on the new version of our website. Access the old version .

Journal of Clinical Medicine, Volume 4, Issue 7

2015 July - 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (10)

  • Article
  • Open Access
5 Citations
6,317 Views
18 Pages

Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients

  • Nicanor Vega-Diaz,
  • Fayna Gonzalez-Cabrera,
  • Silvia Marrero-Robayna,
  • Raquel Santana-Estupiñan,
  • Roberto Gallego-Samper,
  • Fernando Henriquez-Palop,
  • Patricia Perez-Borges and
  • José Carlos Rodriguez-Perez

22 July 2015

Background: In order to reduce the cardiovascular risk, morbidity and mortality of peritoneal dialysis (PD), a minimal level of small-solute clearances as well as a sodium and water balance are needed. The peritoneal dialysis solutions used in combin...

  • Article
  • Open Access
84 Citations
9,284 Views
20 Pages

Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes

  • Christos Argyropoulos,
  • Kai Wang,
  • Jose Bernardo,
  • Demetrius Ellis,
  • Trevor Orchard,
  • David Galas and
  • John P. Johnson

17 July 2015

Microalbuminuria provides the earliest clinical marker of diabetic nephropathy among patients with Type 1 diabetes, yet it lacks sensitivity and specificity for early histological manifestations of disease. In recent years microRNAs have emerged as p...

  • Article
  • Open Access
30 Citations
10,544 Views
18 Pages

14 July 2015

While hypopituitarism after traumatic brain injury (TBI) was previously considered rare, it is now thought to be a major cause of treatable morbidity among TBI survivors. Consequently, recommendations for assessment of pituitary function and replacem...

  • Review
  • Open Access
98 Citations
35,770 Views
15 Pages

Diabetes Insipidus after Traumatic Brain Injury

  • Cristina Capatina,
  • Alessandro Paluzzi,
  • Rosalid Mitchell and
  • Niki Karavitaki

13 July 2015

Traumatic brain injury (TBI) is a significant cause of morbidity and mortality in many age groups. Neuroendocrine dysfunction has been recognized as a consequence of TBI and consists of both anterior and posterior pituitary insufficiency; water and e...

  • Review
  • Open Access
40 Citations
8,067 Views
17 Pages

Impaired Pituitary Axes Following Traumatic Brain Injury

  • Robert A. Scranton and
  • David S. Baskin

13 July 2015

Pituitary dysfunction following traumatic brain injury (TBI) is significant and rarely considered by clinicians. This topic has received much more attention in the last decade. The incidence of post TBI anterior pituitary dysfunction is around 30% ac...

  • Review
  • Open Access
14 Citations
8,983 Views
25 Pages

Diabetic Nephropathy without Diabetes

  • Katia López-Revuelta,
  • Angel A. Méndez Abreu,
  • Carmen Gerrero-Márquez,
  • Ramona-Ionela Stanescu,
  • Maria Isabel Martínez Marín and
  • Elia Pérez Fernández

9 July 2015

Diabetic nephropathy without diabetes (DNND), previously known as idiopathic nodular glomerulosclerosis, is an uncommon entity and thus rarely suspected; diagnosis is histological once diabetes is discarded. In this study we describe two new cases of...

  • Article
  • Open Access
62 Citations
7,702 Views
23 Pages

Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration

  • Sarah Mrejen,
  • Jesse J. Jung,
  • Christine Chen,
  • Samir N. Patel,
  • Roberto Gallego-Pinazo,
  • Nicolas Yannuzzi,
  • Luna Xu,
  • Marcela Marsiglia,
  • Sucharita Boddu and
  • K. Bailey Freund

8 July 2015

With the advent of anti-vascular endothelial growth factor (VEGF) therapy, clinicians are now focused on various treatment strategies to better control neovascular age-related macular degeneration (NVAMD), a leading cause of irreversible blindness. H...

  • Article
  • Open Access
90 Citations
8,343 Views
11 Pages

A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group

  • Brian D. Kelly,
  • Nicola Miller,
  • Karl J. Sweeney,
  • Garrett C. Durkan,
  • Eamon Rogers,
  • Killian Walsh and
  • Michael J. Kerin

7 July 2015

Introduction: Mi(cro)RNAs are small non-coding RNAs whose differential expression in tissue has been implicated in the development and progression of many malignancies, including prostate cancer. The discovery of miRNAs in the blood of patients with...

  • Review
  • Open Access
28 Citations
11,133 Views
21 Pages

26 June 2015

Creatinine is produced in muscle metabolism as the end-product of creatine phosphate and is subsequently excreted principally by way of the kidneys, predominantly by glomerular filtration. Blood creatinine assays constitute the most common clinically...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383